Polymorphisms in STAT4 are highly associated with autoantibody production19 and changes in the promoter accessibility of STAT4 could result from higher IFN-alpha signaling in SLE patients20 or suggests that SLE B cells are epigenetically predisposed for activation of the STAT4 pathway. Here, STAT4 is linked to systemic lupus erythematosus.